Clinical Trial Update: Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a fixed combination therapy (beclometasone + formoterol + glycopyrrolate) to Foster in COPD did complete with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Beclometasone + Formoterol + Glycopyrrolate fixed combination
• Foster (budesonide/formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2026-06-03